Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Tadao, Okuno"'
Publikováno v:
Kanzo. 53:541-548
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f576530ba4a6a124bf9f9d39271e8758
https://doi.org/10.2957/kanzo.53.541
https://doi.org/10.2957/kanzo.53.541
Publikováno v:
Journal of Gastroenterology. 41:151-157
It has been found that the efficacy of lamivudine (LAM) therapy can be improved by preceding administration with a short course of corticosteroid that induces a flare of the disease upon its withdrawal. Because of the side effects of corticosteroid,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c000461892b1b8689645977a9fa5d0ff
https://doi.org/10.1007/s00535-005-1734-5
https://doi.org/10.1007/s00535-005-1734-5
Publikováno v:
Hepatology. 33:1299-1302
A proportion of chronic hepatitis C patients who were treated with interferon have a sustained normalization of transaminase levels after interferon therapy without hepatitis C virus (HCV)-RNA clearance. We determined their clinical characteristics a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a186a839af3209106285be23db40a27
https://doi.org/10.1053/jhep.2001.24100
https://doi.org/10.1053/jhep.2001.24100
Autor:
Tadao Okuno, Michiko Shindo
Publikováno v:
Liver. 20:136-142
Aims: Treatment of chronic hepatitis B patients with interferon (IFN) alpha results in a sustained loss of viral replication in as many as 20–40% of cases. The resistance to antiviral treatment by some viruses is due to positive selection of varian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::968fafa98dc55acc34b7d0f4375d54e5
https://doi.org/10.1034/j.1600-0676.2000.020002136.x
https://doi.org/10.1034/j.1600-0676.2000.020002136.x
Publikováno v:
Journal of Gastroenterology. 34:680-687
We investigated changes in the titers of positive and negative strands of hepatitis G virus (HGV) RNA and hepatitis C virus (HCV) RNA in serum and liver during and 1 to 3 years after interferon therapy in patients with chronic hepatitis C coinfected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acf7525e95ca25ae9321be085d1ecb7e
https://doi.org/10.1007/s005350050319
https://doi.org/10.1007/s005350050319
Publikováno v:
Journal of Gastroenterology and Hepatology. 10:532-537
Multiple hepatic granulomas in chronic hepatitis C patients treated with alpha interferon were recently observed. To assess the presence of hepatic granulomas in chronic hepatitis C, and to determine whether their presence is related to interferon th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1abd92cb2b2257619096c284ee7b7406
https://doi.org/10.1111/j.1440-1746.1995.tb01343.x
https://doi.org/10.1111/j.1440-1746.1995.tb01343.x
Publikováno v:
International Hepatology Communications. 4:126-132
A retrospective study was undertaken to evaluate the efficacy of interferon retreatment in patients with type II 1b -related chronic hepatitis C, and also to determine the most useful predictor of a long-term response to interferon treatment. Twenty-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a66068d7808956f0615ac04b2f8a1fe
https://doi.org/10.1016/0928-4346(95)00233-2
https://doi.org/10.1016/0928-4346(95)00233-2
Publikováno v:
Hepatology. 22:418-425
We investigated anti-hepatitis C virus (HCV) titers, HCV RNA levels in liver and serum, genetic variability in the hypervariable region of the genome, the form of the virus in the circulation, and liver histology in 21 anti-HCV-positive subjects with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3438656909e950b1f26b3dd4d4029d5c
https://doi.org/10.1002/hep.1840220208
https://doi.org/10.1002/hep.1840220208
Autor:
Kanzo Fukuma, Tsutomu Chiba, Teruji Ohoka, Seiichi Himeno, Tadao Okuno, Akira Kawara, Yoshitake Shinji, Kouichi Seki, Tsutomu Imoto, Masato Kasuga, Akio Toudou, Hiroaki Okushin, Kazuya Higashino, Housai Yuu, Hisaichi Hada, Mikio Yamawaki
Publikováno v:
Kanzo. 36:640-648
C型慢性活動性肝炎にHLBI 600万単位(MU)24週間投与を行い,治療初期から週3回投与のI群と初期2週間連日投与後に週3回投与するII群で治療効果に差が認められるか否かを多施設試験にて検討し
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bf96ce807e4a746a8eff693b0325f7c
https://doi.org/10.2957/kanzo.36.640
https://doi.org/10.2957/kanzo.36.640
Publikováno v:
Hepatology (Baltimore, Md.). 58(2)
Hepatocellular carcinoma (HCC) is one of the common sequelae of hepatitis C virus (HCV) infection. It remains controversial, however, whether HCV itself plays a direct role in the development of HCC. Although HCV core, NS3, and NS5A proteins were rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7a4aa454f25be74630042717b2ef99e
https://pubmed.ncbi.nlm.nih.gov/23471816
https://pubmed.ncbi.nlm.nih.gov/23471816